Early intervention with angiotensin-converting enzyme inhibitors during thrombolytic therapy in acute myocardial infarction: Rationale and design of captopril and thrombolysis study
- 1 November 1991
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 68 (14) , 111-115
- https://doi.org/10.1016/0002-9149(91)90267-o
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Effect of Captopril on Progressive Ventricular Dilatation after Anterior Myocardial InfarctionNew England Journal of Medicine, 1988
- TREATMENT OF PATIENTS WITH SYMPTOMLESS LEFT VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL INFARCTIONThe Lancet, 1988
- Neuroendocrine Activation in Acute Myocardial InfarctionJournal of Cardiovascular Pharmacology, 1987
- Haemodynamic Effects of Captopril in Acute Left Ventricular Failure Complicating Myocardial InfarctionJournal of Cardiovascular Pharmacology, 1987
- Preservation of ischemic myocardium by a new converting enzyme inhibitor, enalaprilic acid, in acute myocardial infarctionAmerican Heart Journal, 1985
- Renin and the Complications of Acute Myocardial InfarctionChest, 1984
- The renin-angiotensin-aldosterone system and the clinical course of acute myocardial infarctionEuropean Heart Journal, 1983
- Effects of captopril in acute and chronic heart failure. Correlations with plasma levels of noradrenaline, renin, and aldosterone.Heart, 1983
- Limitation of experimental infarct size by an angiotensin-converting enzyme inhibitor.Circulation, 1982
- Immediate effects of captopril in acute left ventricular failure secondary to myocardial infarctionEuropean Journal of Clinical Investigation, 1981